Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
08 April, 2020 18:22 IST
Caplin Point Labs share price zooms 20% as arm gets nod for cardiac treatment drug
Source: IRIS | 26 Mar, 2020, 01.44PM
Comments  |  Post Comment



Share price of Caplin Point Laboratories jumped more than 13 percent intraday on March 26 after the company got United States Food and Drug Administration (USFDA) approval for Verapamil Hydrochloride injection USP.

Caplin Steriles, a wholly owned subsidiary company of Caplin Point Laboratories Limited, (Q,N,C,F)* has been granted final approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Verapamil Hydrochloride injection USP, 5 mg/2 mL (2.5 mg/mL) and 10 mg/4 mL (2.5 mg/mL) Single-dose vial, a generic therapeutic equivalent version of (RLD), Isoptini injection, 2.5 mg/mL, of Mt. Adams Technologies LLC.

According to IQVIATM (IMS Health), Verapamil Hydrochloride injection USP had US sales data of approximately USD 28 million for the 12-month period ending Dec 2019. Verapamil Hydrochloride is a calcium channel blocker used in the treatment of cardiac conditions such as high blood pressure, arrhythmias and angina.

C.C.Paarthipan, Chairman of Caplin Point Laboratories Limited commented ''We are pleased to receive another approval under Caplin Steriles name and we would be launching this product in the US soon. We're also expecting a couple more approvals shortly, which should enhance our revenue traction in the US.''

The company is also working on a portfolio of 35 simple and complex injectable and ophthalmic products, to be filed over the next 4 years.


Shares of Caplin Point Laboratories  are trading at Rs 244.60, up Rs 40.75, or 19.99%  at the Bombay Stock Exchange (BSE) on Thursday at 12:30 p.m.

The scrip has touched an intra-day high of Rs 244.60 and low of Rs 206.15. The total volume of shares traded at the BSE is 18,242.

In the earlier session, the shares gained 5.21%, or Rs 10.1, at Rs 203.85.

Currently, the stock is trading down  47.51% from its 52-week high of Rs 466.00  and above 35.89% over the 52-week low of Rs 180.00.

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Tata Motors' India sales dips 84% in March - 01-Apr-2020 23:44
Escorts sales fall 54% y-o-y in March - 01-Apr-2020 23:43
Ashok Leyland sales drop 90% in March - 01-Apr-2020 23:42
Maruti Suzuki sales drops by 48% in March 2020 due To COVID-19 lockdown - 01-Apr-2020 23:35
Wipro commits Rs 11.25 bn to tackle coronavirus crisis - 01-Apr-2020 23:09
Wipro commits Rs 11.25 bn to tackle coronavirus crisis - 01-Apr-2020 23:08
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer